Mounjaro Tops India GLP-1 Market by Value as Generics Seize 82% of Semaglutide Units

Eli Lilly's tirzepatide claims the revenue crown in India's fast-bifurcating weight-loss drug market, while generic semaglutide dominates volume—mirroring classic innovator-vs-generic splits in price-sensitive emerging markets.

bt-corporate · 7/8/2026, 4:07:40 PM · Ask about this →